SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 4,017.36 |
Enterprise Value ($M) | 3,629.48 |
Book Value ($M) | 3,305.82 |
Book Value / Share | 25.67 |
Price / Book | 1.22 |
NCAV ($M) | 1,582.49 |
NCAV / Share | 12.29 |
Price / NCAV | 2.54 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.14 |
Return on Assets (ROA) | -0.22 |
Return on Equity (ROE) | -0.23 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 12.75 |
Current Ratio | 12.75 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1,787.98 |
Assets | 3,511.32 |
Liabilities | 205.50 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -569.55 |
Net Income | -463.93 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -452.63 |
Cash from Investing | -2,005.67 |
Cash from Financing | 2,448.51 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Janus Henderson Group Plc | 8.50 | -3.17 | |
13G/A | Fmr Llc | 10.50 | -17.10 | |
13G/A | Ra Capital Management, L.p. | 9.99 | 30.61 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
405,762 | 1,785,670 | 22.72 | |
589,849 | 3,678,725 | 16.03 | |
401,072 | 2,618,287 | 15.32 | |
646,579 | 5,084,325 | 12.72 | |
(click for more detail) |
Similar Companies | |
---|---|
OVID – Ovid Therapeutics Inc. | PBYI – Puma Biotechnology, Inc. |
PCRX – Pacira BioSciences, Inc. | PEPG – PepGen Inc. |
PGEN – Precigen, Inc. |
Financial data and stock pages provided by
Fintel.io